Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial

por Manders, Sofie HM, Kievit, Wietske, Adang, Eddy, Brus, Herman L, Moens, Hein J Bernelot, Hartkamp, Andre, Hendriks, Lidy, Brouwer, Elisabeth, Visser, Henk, Vonkeman, Harald E, Hendrikx, Jos, Jansen, Tim L, Westhovens, Rene, van de Laar, Mart AFJ, van Riel, Piet LCM
Publicado 2015